1.Analysis of Clostridium difficile associated diarrhea in pediatric patients with antibiotic-associated diarrhea.
Guoping CHENG ; Zihua LI ; Xin DAI ; Zaihua WANG ; Ping CAI ; Li CHEN ; Zhen ZHANG
Chinese Journal of Pediatrics 2015;53(3):220-224
OBJECTIVETo analyze the incidence and treatment of Clostridium difficile infection (CDI) in pediatric patients with antibiotic-associated diarrhea (AAD).
METHODClinical data of totally 577 pediatric patients with AAD seen from January 2012 to January 2014 were collected; those children were divided according to age into 4 groups, 0.25 -1 year, >1 -4 years, >4 -12 years and >12 -18 years old groups, and 220 healthy children were enrolled as controls. CDI was tested by C. Diff Quik Chek Complete (QCC) and BD GeneOhm™ C. Diff Assay (BD-PCR) in all children, and the CDI incidence of four groups was added up. All pediatric patients with AAD were divided into mild, general and severe type according to different symptoms of diarrhea, and grading treatment, the general type and severe type of CDI children were treated with metronidazole and (or) vancomycin, afterwards, the results of grading treatment were analyzed.
RESULTThe number of pediatric patients with AAD were 178, 177, 132 and 90 in 0. 25 - 1 year, > 1 -4 years, > 4 - 12 years and > 12 - 18 years old group, respectively. The positive rate of CDI (22. 0% (39/177)) in > 1 -4 years old AAD patients was very significantly higher compared to the controls (4% (4/91), P < 0. 001), the rate of CDI (21. 2% (28/132)) in > 4 - 12 years old AAD pediatric patients was significantly higher compared to the controls (4% (2/53), P = 0. 004), the rates of CDI in 0. 25 - 1 year and > 12 - 18years old AAD groups were not significantly different from that of the controls (P >0. 05). There were 285 mild type AAD children (no CDI children), 176 general type AAD children (including 47 CDI children), and 116 severe type AAD children (including 81 CDI children). After grading and symptomatic treatment, there were 16 recurrent diarrhea in 128 CDI patients (severe type AAD), and the rest recovered. Two cases were transferred for referral treatment, 2 cases died, and the rest 12 recurrent diarrhea children fully recovered after administration of metronidazole, vancomycin, probiotics and symptomatic treatment.
CONCLUSIONThe > 1 -12 years old AAD children had higher CDI rate than healthy children; administration of metronidazole and (or) vancomycin was effective for CD infection.
Adolescent ; Anti-Bacterial Agents ; therapeutic use ; Case-Control Studies ; Child ; Child, Preschool ; Clostridium Infections ; drug therapy ; Clostridium difficile ; Diarrhea ; microbiology ; Humans ; Incidence ; Metronidazole ; therapeutic use ; Probiotics ; therapeutic use ; Vancomycin ; therapeutic use
2.A case of emphysematous hepatitis with spontaneous pneumoperitoneum in a patient with hilar cholangiocarcinoma.
Jung Ho KIM ; Eul Sik JUNG ; Seok Hoo JEONG ; Ju Seung KIM ; Yang Suh KU ; Ki Baik HAHM ; Ju Hyun KIM ; Yeon Suk KIM
The Korean Journal of Hepatology 2012;18(1):94-97
An 80-year-old woman with hilar cholangiocarcinoma was hospitalized due to sudden-onset abdominal pain. Computed tomography revealed hepatic necrosis accompanied with emphysematous change in the superior segment of the right liver (S7/S8), implying spontaneous rupture, based on the presence of perihepatic free air. Although urgent percutaneous drainage was performed, neither pus nor fluids were drained. These findings suggest emphysematous hepatitis with a hepatic mass. Despite the application of intensive care, the patient's condition deteriorated rapidly, and she died 3 days after admission to hospital. Liver gas has been reported in some clinical diseases (e.g., liver abscess) to be caused by gas-forming organisms; however, emphysematous hepatitis simulating emphysematous pyelonephritis is very rare. The case reported here was of fatal emphysematous hepatitis in a patient with hilar cholangiocarcinoma.
Aged, 80 and over
;
Anti-Bacterial Agents/therapeutic use
;
Bile Duct Neoplasms/complications/diagnosis
;
Bile Ducts, Intrahepatic/pathology
;
Cefotaxime/therapeutic use
;
*Cholangiocarcinoma/complications/diagnosis
;
Clostridium Infections/drug therapy/microbiology
;
Clostridium perfringens/isolation & purification
;
Emphysema/complications/*diagnosis
;
Escherichia coli/isolation & purification
;
Escherichia coli Infections/drug therapy/microbiology
;
Female
;
Hepatitis/complications/*diagnosis
;
Humans
;
Metronidazole/therapeutic use
;
*Pneumoperitoneum/complications/diagnosis
;
Tomography, X-Ray Computed
3.Liver Abscess in Advanced Hepatocellular Carcinoma after Sorafenib Treatment.
Seung Kak SHIN ; Young Kul JUNG ; Hyun Hwa YOON ; Oh Sang KWON ; Yun Soo KIM ; Duck Joo CHOI ; Ju Hyun KIM
The Korean Journal of Gastroenterology 2014;63(1):47-50
Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an advanced stage and their tumors are unresectable. Sorafenib is a multi-kinase inhibitor of the vascular endothelial growth factor pathway and was recently introduced as a therapy for advanced HCC. Furthermore, studies have shown that oral sorafenib has beneficial effects on survival. However, many patients experience diverse side effects, and some of these are severe. Liver abscess development has not been previously documented to be associated with sorafenib administration in HCC. Here, we report the case of a HCC patient that developed a liver abscess while being treated with sorafenib.
Anti-Bacterial Agents/therapeutic use
;
Antineoplastic Agents/adverse effects/*therapeutic use
;
Carcinoma, Hepatocellular/*drug therapy/radiography
;
Clostridium/isolation & purification
;
Clostridium Infections/drug therapy/microbiology
;
Humans
;
Liver Abscess/etiology/*microbiology
;
Liver Neoplasms/*drug therapy/radiography
;
Male
;
Middle Aged
;
Niacinamide/adverse effects/*analogs & derivatives/therapeutic use
;
Phenylurea Compounds/adverse effects/*therapeutic use
;
Tomography, X-Ray Computed